Upstream Bio (UPB) Share-based Compensation (2023 - 2026)

Upstream Bio's Share-based Compensation history runs 4 years deep, the most recent figure standing at $43.4 million for Q1 2026.

• On a quarterly basis, Share-based Compensation rose 1547.06% year-over-year to $43.4 million in Q1 2026; TTM through Mar 2026 was $43.4 million, a 442.77% increase from a year earlier, with the FY2025 full-year figure at $21.4 million, up 37.18% from the prior year.
• Share-based Compensation grew to $43.4 million in Q1 2026 per UPB's latest filing, from -$7.8 million in the prior quarter.
• Across five years, Share-based Compensation topped out at $43.4 million in Q1 2026 and bottomed at -$7.8 million in Q4 2025.
• The 4-year median for Share-based Compensation is $1.9 million (2024), against an average of $8.5 million.
• Biggest YoY gain for Share-based Compensation was 1628.05% in 2025; the steepest drop was 475.17% in 2025.
• Year by year, Share-based Compensation stood at $711000.0 in 2023, then jumped by 193.39% to $2.1 million in 2024, then tumbled by 475.17% to -$7.8 million in 2025, then jumped by 654.56% to $43.4 million in 2026.
• Per Business Quant, the three latest UPB Share-based Compensation figures stand at $43.4 million (Q1 2026), -$7.8 million (Q4 2025), and $23.0 million (Q3 2025).